专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

81. 发明申请

WO2019033290A1 METHOD AND APPARATUS FOR IMPLEMENTING NONSTANDARD BANDWIDTH AS WELL AS NETWORK DEVICE COMPRISING THE APPARATUS 审中-公开
公开(公告)号：WO2019033290A1
公开(公告)日：2019-02-21
申请号：PCT/CN2017/097626
申请日：2017-08-16
申请人： TELEFONAKTIEBOLAGET LM ERICSSON (PUBL) , WANG, Li
发明人： WANG, Li , MIAO, Qingyu , TONG, Yanda
IPC分类号： H04W28/06
摘要： Method and apparatus are disclosed for implementing a nonstandard bandwidth at a network device. According to an embodiment, a first amount of physical resource blocks (PRBs) available in the nonstandard bandwidth is determined. A second amount of PRBs available in a standard bandwidth corresponding to the nonstandard bandwidth is determined. A central frequency shift of the nonstandard bandwidth relative to the standard bandwidth is determined based at least on the first and second amounts. A network device comprising the apparatus is also disclosed.

82. 发明申请

WO2015191881A9 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY 审中-公开
公开(公告)号：WO2015191881A9
公开(公告)日：2015-12-17
申请号：PCT/US2015/035371
申请日：2015-06-11
申请人： GREEN, Kathy A. , WANG, Li , NOELLE, Randolph J. , GREEN, William R.
发明人： GREEN, Kathy A. , WANG, Li , NOELLE, Randolph J. , GREEN, William R.
IPC分类号： A61K39/395 , C07K16/18
摘要： The present invention is directed to the use of VISTA agonists alone or in association with other immune inhibitors, preferably another inhibitor of humoral immunity such as an iNOS/NO promoter or nitric oxide or a PD-1 or PD-L1 agonist or a CD40 antagonist for the treatment or prevention of conditions wherein the suppression of humoral immunity is therapeutically beneficial. The present invention is further directed to the use of VISTA antagonists alone or in association with other immune agonists, preferably another enhancer of humoral immunity such as iNOS/NO inhibitor or a PD-1 or PD-L1 antagonist or anti-CTLA-4 antibody or a CD40 agonist for the treatment or prevention of conditions wherein the enhancement of humoral immunity is therapeutically beneficial. Also, the invention relates to the use of VISTA antagonists alone or in association with another immune agonist, e.g., an iNOS/NO inhibitor or a CD40 agonist to promote the efficacy of therapeutic and prophylactic vaccines, e.g., antitumor, and antiviral vaccines.

83. 发明申请

WO2015191881A3 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY 审中-公开
公开(公告)号：WO2015191881A3
公开(公告)日：2015-12-17
申请号：PCT/US2015/035371
申请日：2015-06-11
申请人： GREEN, Kathy A. , WANG, Li , NOELLE, Randolph J. , GREEN, William R.
发明人： GREEN, Kathy A. , WANG, Li , NOELLE, Randolph J. , GREEN, William R.
IPC分类号： A61K39/395 , C07K16/18
摘要： The present invention is directed to the use of VISTA agonists alone or in association with other immune inhibitors, preferably another inhibitor of humoral immunity such as an iNOS/NO promoter or nitric oxide or a PD-1 or PD-L1 agonist or a CD40 antagonist for the treatment or prevention of conditions wherein the suppression of humoral immunity is therapeutically beneficial. The present invention is further directed to the use of VISTA antagonists alone or in association with other immune agonists, preferably another enhancer of humoral immunity such as iNOS/NO inhibitor or a PD-1 or PD-L1 antagonist or anti-CTLA-4 antibody or a CD40 agonist for the treatment or prevention of conditions wherein the enhancement of humoral immunity is therapeutically beneficial. Also, the invention relates to the use of VISTA antagonists alone or in association with another immune agonist, e.g., an iNOS/NO inhibitor or a CD40 agonist to promote the efficacy of therapeutic and prophylactic vaccines, e.g., antitumor, and antiviral vaccines.

84. 发明申请

WO2015191881A2 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY 审中-公开
标题翻译：使用VISTA激动剂和拮抗剂来抑制或增强人体免疫力
公开(公告)号：WO2015191881A2
公开(公告)日：2015-12-17
申请号：PCT/US2015/035371
申请日：2015-06-11
申请人： GREEN, Kathy A. , WANG, Li , NOELLE, Randolph J. , GREEN, William R.
发明人： GREEN, Kathy A. , WANG, Li , NOELLE, Randolph J. , GREEN, William R.
IPC分类号： A61K39/395 , A61K31/198
CPC分类号： A61K39/3955 , A61K31/198 , A61K39/39541 , A61K45/06 , C07K16/2827 , C07K2317/76 , A61K2300/00
摘要： The present invention is directed to the use of VISTA agonists alone or in association with other immune inhibitors, preferably another inhibitor of humoral immunity such as an iNOS/NO promoter or nitric oxide or a PD-1 or PD-L1 agonist or a CD40 antagonist for the treatment or prevention of conditions wherein the suppression of humoral immunity is therapeutically beneficial. The present invention is further directed to the use of VISTA antagonists alone or in association with other immune agonists, preferably another enhancer of humoral immunity such as iNOS/NO inhibitor or a PD-1 or PD-L1 antagonist or anti-CTLA-4 antibody or a CD40 agonist for the treatment or prevention of conditions wherein the enhancement of humoral immunity is therapeutically beneficial. Also, the invention relates to the use of VISTA antagonists alone or in association with another immune agonist, e.g., an iNOS/NO inhibitor or a CD40 agonist to promote the efficacy of therapeutic and prophylactic vaccines, e.g., antitumor, and antiviral vaccines.
摘要翻译：本发明涉及单独或与其它免疫抑制剂，优选另一种体液免疫抑制剂如iNOS / NO启动子或一氧化氮或PD-1或PD-L1激动剂或CD40拮抗剂相结合的VISTA激动剂的用途用于治疗或预防其中抑制体液免疫是治疗有益的条件。本发明还涉及单独使用或与其它免疫激动剂，优选体液免疫的另一增强剂如iNOS / NO抑制剂或PD-1或PD-L1拮抗剂或抗CTLA-4抗体联合使用的VISTA拮抗剂或用于治疗或预防其中增强体液免疫是治疗有益的条件的CD40激动剂。此外，本发明涉及单独或与另一种免疫激动剂例如iNOS / NO抑制剂或CD40激动剂联合以增强治疗性和预防性疫苗（例如抗肿瘤剂和抗病毒疫苗）的功效的用途。

85. 发明申请

WO2015056191A1 POLARIZER AND A METHOD FOR FORMING THE SAME 审中-公开
标题翻译：偏振器及其形成方法
公开(公告)号：WO2015056191A1
公开(公告)日：2015-04-23
申请号：PCT/IB2014/065338
申请日：2014-10-15
申请人： EULITHA A.G. , SOLAK, Harun , WANG, Li
发明人： SOLAK, Harun , WANG, Li
IPC分类号： G02B5/18 , G02B5/30
CPC分类号： G02B5/3058 , G02B5/1809
摘要： A method for manufacturing a bi-layer wire-grid polarizer, which method includes forming a periodic pattern of alternating and parallel pre-formed lines and grooves on a surface of a substrate, depositing polarizing material onto the pattern to form a top wire of polarizing material having a first width on the top of each pre-formed line and a bottom wire of polarizing material having a second width on the bottom of each groove, each top wire and each of its neighbouring bottom wires having a lateral separation between them, and enlarging the lateral separation between each top wire and each of its neighbouring bottom wires by at least one of increasing the period of the periodic pattern and reducing the first and second widths of the respective top and bottom wires, whereby certain desired transmission and/or polarization properties of the bi-layer wire-grid polarizer are obtained.
摘要翻译：一种用于制造双层线栅偏振器的方法，该方法包括在衬底的表面上形成交替和平行的预制线和凹槽的周期性图案，将偏振材料沉积到图案上以形成极化的顶部线在每个预成形线的顶部具有第一宽度的材料和在每个凹槽的底部上具有第二宽度的偏振材料的底部线，每个顶部线及其每个相邻的底部线在它们之间具有横向间隔;以及通过增加周期性图案的周期并减小相应的顶部和底部线的第一和第二宽度中的至少一个来扩大每个顶部线及其每个相邻底部线之间的横向间隔，由此某些期望的透射和/或极化获得双层线栅偏振器的特性。

86. 发明申请

WO2015042905A1 CABLE MANAGEMENT SYSTEM FOR MEDICAL TREATMENT DEVICE 审中-公开
标题翻译：医疗处理设备电缆管理系统
公开(公告)号：WO2015042905A1
公开(公告)日：2015-04-02
申请号：PCT/CN2013/084576
申请日：2013-09-29
申请人： COVIDIEN LP , WANG, Li
发明人： WANG, Li , ZHANG, Quan , HONG, Chunlang
IPC分类号： H02G11/02 , H01R13/72
CPC分类号： A61B19/0256 , A61B18/1206 , A61B18/18 , A61B50/20 , A61B2018/00178 , A61B2050/21 , B65H75/28 , B65H75/40 , B65H75/4473 , B65H2701/34
摘要： -24- IEM130028PCT ABSTRACT OF THE DISCLOSURE An enclosure of a power source for medical treatment devices includes a handle portion extending from a first surface of the enclosure. The handle portion includes a standoff extending away from the first surface, and a flange extending transversely from the standoff and defining a plane that is generally parallel to the first surface. Together, the first surface, the standoff, and the flange define an open annular space. A power cable may be wound about the standoff to at least partially occupy the open annular space. One or more notches in the flange are configured to seat the power cable to secure its loose end(s). In this manner, the power cable can be safely stored to reduce the risks that the power cable may become damaged, may interfere with other devices in the treatment area, or may be misplaced.
摘要翻译：本发明摘要用于医疗处理装置的电源的外壳包括从外壳的第一表面延伸的手柄部分。手柄部分包括远离第一表面延伸的支座，以及从支座横向延伸并限定大致平行于第一表面的平面的凸缘。一起，第一表面，隔离物和凸缘限定开放的环形空间。电力电缆可以围绕支架缠绕以至少部分地占据开放的环形空间。法兰中的一个或多个凹口被配置为安置电源电缆以固定其松动的端部。以这种方式，可以安全地存储电力电缆，以减少电力电缆可能被损坏的风险，可能干扰处理区域中的其他设备，或者可能放错位置。

87. 发明申请

WO2012151503A3 MULTIPLEXED GENETIC REPORTER ASSAYS AND COMPOSITIONS 审中-公开
公开(公告)号：WO2012151503A3
公开(公告)日：2012-11-08
申请号：PCT/US2012/036558
申请日：2012-05-04
申请人： THE BROAD INSTITUTE, INC. , MIKKELSEN, Tarjei , GNIRKE, Andreas , MELNIKOV, Alexandre , LANDER, Eric, S. , WANG, Li , ZHANG, Xiaolan
发明人： MIKKELSEN, Tarjei , GNIRKE, Andreas , MELNIKOV, Alexandre , LANDER, Eric, S. , WANG, Li , ZHANG, Xiaolan
IPC分类号： C12N15/63 , C12N15/11
摘要： The invention provides methods for determining the activity of a plurality of nucleic acid regulatory elements. These methods may facilitate, e.g., the systematic reverse engineering, and optimization of mammalian cis-regulatory elements at high resolution and at a large scale. The method may include integration of multiplexed DNA synthesis and sequencing technologies to generate and quantify the transcriptional regulatory activity of, e.g., thousands of arbitrary DNA sequences in parallel in cell-based assays (e.g., mammalian cell based assays).

88. 发明申请

WO2011140528A1 SUBSTRATES AND METHODS OF FORMING FILM STRUCTURES TO FACILITATE SILICON CARBIDE EPITAXY 审中-公开
标题翻译：形成薄膜结构的基板和方法来加固硅碳化物外延
公开(公告)号：WO2011140528A1
公开(公告)日：2011-11-10
申请号：PCT/US2011/035655
申请日：2011-05-06
申请人： QS SEMICONDUCTOR AUSTRALIA PTY LTD. , DIMITRIJEV, Sima , WANG, Li , HAN, Jisheng , IACOPI, Alan , HARRISON, Herbert Barry
发明人： DIMITRIJEV, Sima , WANG, Li , HAN, Jisheng , IACOPI, Alan , HARRISON, Herbert Barry
IPC分类号： H01L21/329 , C23C16/02 , C23C16/32
CPC分类号： H01L21/02529 , H01L21/02381 , H01L21/02488 , H01L21/0262 , H01L21/02658
摘要： Embodiments of the invention relate generally to semiconductors and semiconductor fabrication techniques, and more particularly, to devices, integrated circuits, substrates, wafers and methods to form film structures to facilitate formation of silicon carbide epitaxy on a substrate, such as a silicon-based substrate. In some embodiments, a method of preparing a substrate for silicon carbide epitaxial layer formation can include forming an ultrathin layer of oxide that is configured to inhibit contaminants from interacting with a silicon-based substrate. Further, the method can include forming a carbonized film on the silicon-based substrate that is configured to inhibit contaminants from interacting with the silicon-based substrate. The carbonized film can be configured to be transitory as fabrication parameters are modified to form an epitaxial layer of silicon carbide.
摘要翻译：本发明的实施方案一般涉及半导体和半导体制造技术，更具体地涉及用于形成薄膜结构以便于在诸如硅基底材的基底上形成碳化硅外延的器件，集成电路，衬底，晶片和方法。在一些实施例中，制备用于碳化硅外延层形成的衬底的方法可包括形成被配置为抑制污染物与硅基衬底相互作用的氧化物超薄层。此外，该方法可以包括在硅基衬底上形成碳化膜，其被配置为抑制污染物与硅基衬底相互作用。当制造参数被修改以形成碳化硅的外延层时，碳化膜可以被配置为短暂的。

89. 发明申请

WO2011072246A2 TAL EFFECTOR-MEDIATED DNA MODIFICATION 审中-公开
公开(公告)号：WO2011072246A2
公开(公告)日：2011-06-16
申请号：PCT/US2010/059932
申请日：2010-12-10
申请人： REGENTS OF THE UNIVERSITY OF MINNESOTA , IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. , VOYTAS, Daniel F. , BOGDANOVE, Adam , ZHANG, Feng , CHRISTIAN, Michelle , CERMAK, Tomas , SCHMIDT, Clarice Lauer , DOYLE, Erin , WANG, Li
发明人： VOYTAS, Daniel F. , BOGDANOVE, Adam , ZHANG, Feng , CHRISTIAN, Michelle , CERMAK, Tomas , SCHMIDT, Clarice Lauer , DOYLE, Erin , WANG, Li
IPC分类号： C12N15/10
CPC分类号： C12N9/22 , C12N15/01 , C12N15/102 , C12N15/1082 , C12N15/62 , C12N15/63 , C12Y301/21004
摘要： Materials and methods related to gene targeting (e.g., gene targeting with transcription activator-like effector nucleases; "TALENS") are provided.
摘要翻译：提供了与基因靶向相关的材料和方法（例如，用转录激活子样效应核酸酶进行基因靶向;“TALENS”）。

90. 发明申请

WO2010099864A1 PROCESS FOR PREPARING ALLOY COMPOSITE NEGATIVE ELECTRODE MATERIAL FOR LITHIUM ION BATTERIES 审中-公开
标题翻译：锂离子电池合金复合电极材料的制备工艺
公开(公告)号：WO2010099864A1
公开(公告)日：2010-09-10
申请号：PCT/EP2010/000927
申请日：2010-02-16
申请人： UMICORE , TSINGHUA UNIVERSITY , REN, Jianguo , HE, Xiangming , WANG, Li , YAN, Runbao , PU, Weihua , Ll, Jianjun , GAO, Jian
发明人： REN, Jianguo , HE, Xiangming , WANG, Li , YAN, Runbao , PU, Weihua , Ll, Jianjun , GAO, Jian
IPC分类号： H01M4/04 , H01M4/133 , H01M4/1393
CPC分类号： H01M4/38 , H01M4/42 , H01M4/46 , H01M4/583 , H01M4/587 , H01M4/625 , H01M2004/027
摘要： The present invention relates to a process for preparing an alloy composite negative electrode material having a spherical carbon matrix structure for lithium ion batteries by spray-drying carbothermal reduction. The invention covers a process for preparing a negative electrode material for a lithium ion battery with a general formula A-M/Carbon, wherein A is a metal selected from the group consisting of Si, Sn, Sb, Ge and Al; and wherein M is different from A and is at least one element selected from the group consisting of B, Cr, Nb, Cu, Zr, Ag, Ni, Zn, Fe, Co, Mn, Sb, Zn, Ca, Mg, V, Ti, In, Al, Ge; and comprising the steps of: - providing a solution comprising an organic polymer and either chemically reducible nanometric A- and M-precursor compounds, or nanometric Si and a chemically reducible M-precursor compound, when said metal A is Si; - spray-drying said solution whereby a A- and M-precursor bearing polymer powder is obtained, and - calcining said powder in a neutral atmosphere at a temperature between 500 and 1000° C for 3 to 10 hours whereby, in this carbothermal reduction, a carbon matrix is obtained bearing homogeneously distributed A-M alloy particles.
摘要翻译：本发明涉及通过喷雾干燥碳热还原制备具有锂离子电池的球形碳基质结构的合金复合负极材料的方法。本发明涉及一种制备具有通式A-M /碳的锂离子电池用负极材料的方法，其中A为选自Si，Sn，Sb，Ge和Al的金属; 其中M与A不同，为选自B，Cr，Nb，Cu，Zr，Ag，Ni，Zn，Fe，Co，Mn，Sb，Zn，Ca，Mg，V中的至少一种元素，Ti，In，Al，Ge; 并且包括以下步骤：当所述金属A为Si时，提供包含有机聚合物和化学还原性纳米A和M前体化合物或纳米Si和化学还原性M前体化合物的溶液; - 喷雾干燥所述溶液，由此获得具有A和M前体的聚合物粉末，并且在中性气氛中在500-1000℃的温度下煅烧所述粉末3至10小时，由此在该碳热还原中，得到带有均匀分布的AM合金颗粒的碳基体。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式